Today at the Open Plenary of the Fair Pricing Forum, Kris Torgeson, Executive Director of MSF Access, delivered a strong message on how to overcome affordability and transparency barriers. Here are the four key points she made.
👇
👇
MSF Access
@MSF_access
We advocate for access to & development of lifesaving medicines, tests & vaccines for people in MSF programmes & beyond. #MedicinesShouldntBeALuxury
1.1K Following 24K Followers 16K Posts
Latest posts 5
💉First participant vaccinated in Tumaini!
Tumaini, a pivotal Phase 2/3 vaccine trial for the Bundibugyo virus causing #Ebola, will work closely with affected communities, health authorities and outbreak response partners to generate robust evidence.
Tumaini, a pivotal Phase 2/3 vaccine trial for the Bundibugyo virus causing #Ebola, will work closely with affected communities, health authorities and outbreak response partners to generate robust evidence.
The ongoing Bundibugyo #Ebola virus (BDBV) outbreak has highlighted significant challenges in controlling transmission.
With currently no specific vaccine licensed against BDBV, we examined four vaccine candidates through an access lens: msfaccess.org/vaccines-2026-…
With currently no specific vaccine licensed against BDBV, we examined four vaccine candidates through an access lens: msfaccess.org/vaccines-2026-…
msfaccess.org Vaccines for the 2026 Bundibugyo Ebola disease outbreak: access gaps and recommendations Technical brief on BDBV vaccine candidates, featuring access gaps and recommendations. Rupa Narra is an MSF pediatrician who recently worked at an #Ebola treatment center in North Kivu, Democratic Republic of Congo, where she witnessed a harsh reality for children facing a disproportionately high risk of death.
2:18
Children cannot continue to wait.
“Treatments, vaccines, and other preventive tools should be evaluated for use in children from the outset of research efforts and made available to them without delay,” says Dr Manangama, epidemiologist and deputy director of operations at MSF.
“Treatments, vaccines, and other preventive tools should be evaluated for use in children from the outset of research efforts and made available to them without delay,” says Dr Manangama, epidemiologist and deputy director of operations at MSF.
Children are being left behind in the research of innovative medical tools for the current Ebola disease outbreak in DRC.View quoted post on X
Children are also disproportionately impacted by the outbreak, with the youngest facing the highest risk of death.
msf.org/children-are-b…
